Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

The review suggests there's no agreed treatment for Frontal Fibrosing Alopecia, but hydroxychloroquine and 5a-reductase inhibitors are most effective. New treatments like platelet-rich plasma and LED light could help if standard treatments fail.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

A new lotion with halobetasol and tazarotene successfully treats acne keloidalis nuchae.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

Current treatments for alopecia show no significant long-term benefits.

Coal tar shampoos, salicylic acid, and topical corticosteroids are effective for scalp psoriasis, with Vitamin D3 analogues also showing benefits; severe cases may require stronger medication with more risks.

Hair transplants can effectively treat hair loss from CCCA in African American women if there's no inflammation.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

The document says that there are treatments for hair and nail diseases.

More research is needed to find the best treatment for dissecting cellulitis of the scalp.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

There is no standard treatment for CCCA, and practices vary widely.

A new plant-based treatment was effective for hair regrowth in women with a specific type of hair loss that didn't respond to usual treatments.

The conclusion is that emotional support and a variety of treatments are important for alopecia areata, but more research is needed.

Hair care practices like using relaxers and tight braiding can lead to permanent hair loss in black women.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.